Ibogaine treatment centers are not licensed, inspected, or certified by any regulatory body in the countries where they currently operate. This matters because the quality range is wide — and the distance between a well-run center and a dangerous one is not visible from the outside. The only reliable evaluation framework is the medical infrastructure each center includes or omits.
An ibogaine treatment center is a supervised facility administering ibogaine — a naturally occurring alkaloid from Tabernanthe iboga — for addiction, PTSD, and treatment-resistant depression. Required pre-ceremony elements at any legitimate center: 12-lead EKG, complete blood panel, medication review, and a medical professional on-site for the full 12–24 hour ceremony. Cost in Canada ranges from $2,000–$5,000 CAD.

Where Ibogaine Treatment Centers Operate
Ibogaine treatment centers exist in a small number of countries. The United States is not one of them. Ibogaine has been Schedule I since 1970 — classified before the clinical research existed — and there is no legal pathway for treatment outside federally supervised trials. As covered separately, the practical effect is that most Americans seeking treatment access it outside the country.
Canada is the most geographically accessible alternative for North Americans. Ibogaine is not listed under Canada's Controlled Drugs and Substances Act — it is not prohibited, though it is also not approved for medical use. British Columbia has the highest concentration of providers. Vancouver is approximately 45 minutes from the US border by car, making it the most accessible option for people in the Pacific Northwest.
Mexico has the largest number of ibogaine treatment centers by volume, with prices running $4,000–$12,000+ USD. The quality range is correspondingly wide: from facilities with full medical infrastructure to operations with very little. The due diligence burden on anyone looking at Mexico is higher than Canada precisely because the provider pool is larger and more variable.
Other legal jurisdictions include Portugal, the Netherlands, Jamaica, and Costa Rica. Some providers in these countries operate with strong medical protocols. Others offer ibogaine within a wellness retreat model, which is not the same thing. The evaluation criteria apply regardless of country. What matters is the specific medical infrastructure at the specific center — not where it is located.
What Every Legitimate Ibogaine Treatment Center Must Include
These elements are not optional at a legitimate ibogaine treatment center. They are the minimum standard for safe administration — and they are what separates a center that is operating safely from one that is not.
Pre-ceremony medical screening — all four components, before any ceremony date is confirmed:
- 12-lead EKG. Ibogaine prolongs the QT interval — the electrical recovery period between heartbeats — in all participants. QT prolongation, significant arrhythmia, or recent myocardial infarction are absolute contraindications. The EKG identifies these conditions before ceremony. A center that does not require one is not identifying them.
- Complete blood panel. Liver function tests (ALT, AST, bilirubin) and kidney function markers (creatinine, GFR) are required because ibogaine is metabolised hepatically. Severe liver or kidney disease alters clearance in ways that amplify both therapeutic and adverse effects.
- Full medication review. SSRIs and SNRIs require a supervised taper before ceremony — not as a preference, but because combining serotonin-active compounds creates real risk of serotonin syndrome, which in severe cases is fatal. Methadone requires a specific transition protocol. Lithium and most antipsychotics require individual assessment.
- Psychiatric history assessment. Active psychosis and schizophrenia spectrum disorders are absolute contraindications. A personal history of psychosis requires careful evaluation — not an automatic no, but a thorough review before any ceremony date is appropriate.
On-site medical professional throughout the full ceremony.The 12–24 hour active experience is when ibogaine's cardiac effects are most acute. A physician or registered nurse — not a facilitator, not a remote number to call — must be physically present for the duration. Centers that describe “medical oversight” while offering only a number to call in an emergency are not providing medical supervision. They are providing liability cover.
Continuous cardiac monitoring during ceremony.Pre-ceremony EKG clears a candidate before dosing. Continuous ECG monitoring throughout the experience is what identifies cardiac events during the active phase — when ibogaine's QT-prolonging effect is present in all participants regardless of initial screening results.
The 2023 Stanford study published in Nature Medicine found 88% reductions in PTSD symptoms, 87% in depression, and 81% in anxiety at one month in 30 special operations veterans with treatment-resistant conditions. That study was conducted under full medical monitoring. Those numbers do not describe what ibogaine produces in unmonitored settings.
Structured integration support.Noribogaine — ibogaine's active metabolite — sustains weeks to months of elevated neuroplasticity after ceremony ends. It is during this window that lasting change is most accessible. Centers that provide nothing after ceremony are offering the medicine without the mechanism that produces lasting outcomes. The research on ibogaine outcomes is consistent on this: integration support is the primary determinant of long-term results.

How to Evaluate an Ibogaine Treatment Center Before Booking
Because no certification body exists, the evaluation falls entirely on the person seeking treatment. These are the questions that separate a legitimate center from one that is not.
Ask specifically about cardiac monitoring.Is a 12-lead EKG required before acceptance? Is a physician or registered nurse physically on-site throughout the active experience — not on call, physically present? What cardiac monitoring equipment runs during ceremony? Vague answers to these questions are informative. “We have medical oversight” means nothing. “A licensed physician monitors continuous ECG telemetry throughout the experience” means something.
Ask what the price includes. Some clinics bill medical screening separately — typically $300–$800 in addition to programme fees. This is not automatically a red flag. What matters is that the screening happens. Ask specifically whether the price includes the on-site physician, the monitoring equipment, and the recovery days following ceremony.
Ask about their process for SSRIs and methadone. A center that accepts participants currently on SSRIs without a documented completed taper, or accepts methadone patients without a transition protocol, is not screening adequately. These are the two situations where intake conversations end in a no at a legitimate center — and where they do not end in a no at an unsafe one.
End the conversation if:the center does not require an EKG before confirming a ceremony date; the answer to “who is your on-site medical professional during ceremony?” is vague or deflected; the programme is priced below $3,000 USD; or you are being pressured to book quickly. These are not minor concerns. They are the specific infrastructure cuts that correlate with adverse outcomes.
What Cost Signals About a Center's Safety Infrastructure
Providers charging significantly below market rate are not being generous. They are removing something from the process — and at ibogaine treatment centers, what gets removed is almost always safety infrastructure.
The cost of an on-site physician for a 12–24 hour ceremony, continuous cardiac monitoring equipment, and complete pre-ceremony screening is real. At Transcend in Vancouver, iboga ceremony costs $2,000–$5,000 CAD — reflecting the on-site medical professional, continuous monitoring, the medicine, and facilitation. Integration coaching is $150–$300 CAD per session.
In Mexico, where costs run $4,000–$12,000+ USD, the price is a reasonable proxy for what is present. Budget programmes at $3,500–$6,000 USD almost always lack either a physician on-site (as opposed to a nurse on call), continuous ECG telemetry, or adequate recovery support. The Mexico cost guide covers what each tier typically includes and what gets removed at the lower end.
Price is not the only consideration — a high-priced center can still be inadequately staffed. But a low price is a reliable signal that something necessary is absent. The relevant question is not which center charges less. It is which center can specifically account for every component of its medical infrastructure.
What Ibogaine Treatment Centers Cannot Guarantee
A center can provide a medically safe experience. It cannot determine what a person does with what that experience produces.
The ceremony opens a window. Noribogaine — ibogaine's active metabolite — sustains weeks to months of elevated neuroplasticity after the active experience ends. It is during this period that lasting change is most accessible. It is not the ceremony itself. It is the 4–6 weeks that follow.
The pattern is consistent enough to be treated as reliable. A person leaves with clarity, reduced craving, and what feels like the beginning of something different. Six weeks later, having returned immediately to the same environment, the same relationships, and the same unaddressed conditions, they are back where they started — or in a harder position, because the contrast between what was possible and what they returned to is now sharper.
This is not a failure of the medicine. It is the predictable outcome of ceremony without integration. Centers that present the experience as the primary deliverable are not accurately describing the process. The ceremony is the beginning. Integration coaching is the work that uses what the ceremony produced. MAPS research on ibogaine and the broader observational literature consistently show that post-ceremony support is the primary predictor of sustained outcomes — not the ceremony itself.
The people who arrive at legitimate centers having exhausted conventional options first tend to have better outcomes than those for whom this is a first attempt. Not because the medicine works differently for them — but because they are not naive about the difficulty of what they are attempting. They have evidence that other approaches were not enough. That scepticism, earned the hard way, tends to produce a quality of engagement in the weeks after ceremony that first-attempt participants rarely match.
Who Is Not a Candidate for Ibogaine Treatment
Medical contraindications apply at every ibogaine treatment center regardless of country, price, or reputation. These do not change based on how much someone wants access.
Absolute contraindications — these disqualify regardless of circumstance:
- QT prolongation, significant cardiac arrhythmia, or recent myocardial infarction. Ibogaine prolongs the QT interval in all participants. In people with pre-existing cardiac conditions, this creates real risk of fatal arrhythmia. This is the mechanism behind most documented ibogaine fatalities. An EKG identifies it before ceremony. Any center that does not require one is not identifying it.
- SSRIs or SNRIs without a completed supervised taper. Serotonin syndrome risk is real and potentially fatal. A taper, conducted with the prescribing physician, is required — not a few days off the medication, a full supervised taper. There are no exceptions.
- Methadone without a supervised transition protocol.Methadone's long half-life and its own cardiac effects require a medically managed transition over weeks. Centers that admit methadone patients without this protocol are not screening adequately.
- Severe liver or kidney disease. Ibogaine is metabolised hepatically. Impaired clearance alters elimination and amplifies risk.
- Active psychosis or schizophrenia spectrum disorder. Ibogaine amplifies what is present. This is not a path to stability for someone in an actively destabilised state.
- Lithium and certain other psychiatric medications. The interaction profile requires individual medical review before any ceremony is appropriate.
- Pregnancy. An absolute contraindication. No protocol changes this.
Someone in acute psychiatric crisis is also not an appropriate candidate — regardless of how much they want access. The experience amplifies what is present. Entering ceremony in a state of acute instability does not produce stability.
The intake conversation at Transcend ends in a no more often than most people expect. The people who receive that no include those with cardiac conditions that make ibogaine genuinely dangerous, those on medications that cannot be safely tapered in a reasonable timeframe, and those in states that require a different kind of support first. That is not a rejection. It is the intake process doing what it is supposed to do. A center that does not say no to these cases is not screening — it is billing.
Is This Right for You?
The ceremony page covers the full process at Transcend — from application through recovery and integration. The FAQ addresses the most common questions about screening, medications, timing, and what the experience involves. If you have completed ceremony elsewhere and are looking for structured post-ceremony support, the integration page covers what that work looks like.
Every application at Transcend receives a personal response within 2–3 business days. If ibogaine treatment is not appropriate for you at this moment, we will say so directly. To begin that conversation, apply here or reach out at jake.nylund@gmail.com.